N-ethylidenecyclohexylamine | 113832-57-8

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-ethylidenecyclohexylamine
• 英文别名: N-(ethylidene)-cyclohexylamine；ethylidene-N-cyclohexylamine；ethylidene cycohexylamine；N-ethylidenecyclohexanamine；cyclohexyl-(E)-ethylidene-amine
• CAS: 113832-57-8
• 化学式: C₈H₁₅N
• 分子量: 125.214
• InChiKey: QWMYJOXBVBZDJM-XNWCZRBMSA-N

物化性质

• 沸点：
  54 °C(Press: 18 Torr)
• 密度：
  0.8716 g/cm3(Temp: 0 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  2.41
• 重原子数：
  9.0
• 可旋转键数：
  1.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  12.36
• 氢给体数：
  0.0
• 氢受体数：
  1.0

反应信息

• 作为反应物：
  描述：

  N-ethylidenecyclohexylamine 在 重氮乙酸乙酯 作用下， 生成 1-(cyclohexylimino)-2-butene
  参考文献：
  名称：

  Baret,P. et al., Bulletin de la Societe Chimique de France, 1972, p. 2493 - 2501

  摘要：

  DOI：
• 作为产物：
  描述：

  乙醛 生成 N-ethylidenecyclohexylamine
  参考文献：
  名称：

  LALONDE, J. J.;BERGBREITER, D. E.;NEWCOMB, M., J. ORG. CHEM., 1986, 51, N 8, 1369-1372

  摘要：

  DOI：

文献信息

• [EN] COMPOUNDS USEFUL FOR THE TREATMENT OF INFECTION WITH MANNHEIMIA HAEMOLYTICA OR HISTOPHILUS SOMNI<br/>[FR] COMPOSÉS UTILES POUR LE TRAITEMENT D'UNE INFECTION PAR MANNHEIMIA HAEMOLYTICA OU HISTOPHILUS SOMNI
  申请人：INTERVET INT BV

  公开号：WO2020002234A1

  公开（公告）日：2020-01-02

  The present invention discloses compounds that are useful in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD)

  本发明公开了一种在治疗动物呼吸道疾病，特别是牛或猪呼吸道疾病（BRD和SRD）方面有用的化合物。
• Antihypercholesterolemic alkylene compounds
  申请人：Bristol-Myers

  公开号：US05011947A1

  公开（公告）日：1991-04-30

  Compounds of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 each are independently hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy or trifluoromethyl; R is C.sub.1-7 alkyl, C.sub.3-6 cycloalkyl, fluoromethyl, difluoromethyl, trifluoromethyl; A is ##STR2## R.sup.5 is hydrogen, a hydrolyzable ester group or a cation to form a non-toxic pharmaceutically acceptable salt, are novel antihypercholesterolemic agents which inhibit cholesterol biosynthesis. Intermediates and processes for their preparation are disclosed.

  该公式化合物的化合物##STR1##其中R.sup.1、R.sup.2、R.sup.3和R.sup.4分别独立地是氢、卤素、C.sub.1-4烷基、C.sub.1-4烷氧基或三氟甲基；R是C.sub.1-7烷基、C.sub.3-6环烷基、氟甲基、二氟甲基、三氟甲基；A是##STR2##R.sup.5是氢、可水解酯基或阳离子，形成无毒的药用可接受盐，是抑制胆固醇生物合成的新型抗高胆固醇药物。公开了其制备的中间体和过程。
• NOVEL NONLINEAR CHROMOPHORES ESPECIALLY SUITED FOR USE IN ELECTRO-OPTICAL MODULATION
  申请人：Bretonniere Yann

  公开号：US20130123508A1

  公开（公告）日：2013-05-16

  The present invention relates to heptamethine hemicyanine chromophores of formula (I): where R 1 , R 2 , R 3 , R 4 , R′ 4 , R 5 , R′ 5 , R 6 , R′ 6 , R 7 , X, Y 1 and Y 2 are as defined in claim 1 , to the method for preparing same as well as to the use of such chromophores for the second-order nonlinear optical property thereof.

  本发明涉及式(I)的七甲基半青光染料，其中R1、R2、R3、R4、R′4、R5、R′5、R6、R′6、R7、X、Y1和Y2如权利要求1所定义，以及制备同类物质的方法，以及利用这种染料的二阶非线性光学性质。
• 4-fluorobiphenyl derivatives
  申请人：Fujirebio Inc.

  公开号：US05523460A1

  公开（公告）日：1996-06-04

  A 4-fluorobiphenyl derivative of formula (I), which is useful as a cholesterol lowering agent or a lipid lowering agent because of its strong inhibitory effect on HMG-CoA reductase), and which is also useful as an intermediate for producing the above-mentioned cholesterol lowering agent or lipid lowering agent: ##STR1## wherein A is a .omega.-oxycarbonyldihydroxybutyl group, a tetrahydropyranyl group, a .omega.-oxycarbonyl-3-oxobutyl group, a formyl group, or a cyano group; R.sup.1 is a halogen atom, an alkyl group, or a group represented by R.sup.5 O--, wherein R.sup.5 is a hydrogen atom, or an alkyl group; R.sup.2 is a hydrogen atom, an alkyl group; R.sup.3 is a hydrogen atom, or an alkyl group; R.sup.5 and R.sup.2 may form a five-membered ring or a six-membered ring in combination with the oxygen atoms to which R.sup.5 and R.sup.2 are respectively bonded, and R.sup.5 and R.sup.3 may form a five-membered ring or a six-membered ring in combination with the oxygen atom to which R.sup.5 is bonded.

  一种具有化学式（I）的4-氟联苯衍生物，由于其对HMG-CoA还原酶具有强烈的抑制作用，可用作降胆固醇剂或降脂剂，并且还可用作生产上述降胆固醇剂或降脂剂的中间体：##STR1## 其中A是ω-氧羰基二羟基丁基基团、四氢吡喃基团、ω-氧羰基-3-氧代丁基基团、甲酰基团或氰基；R1是卤素原子、烷基基团或由R5 O--表示的基团，其中R5是氢原子或烷基基团；R2是氢原子或烷基基团；R3是氢原子或烷基基团；R5和R2可以分别与它们相结合的氧原子形成五元环或六元环，R5和R3可以与R5结合的氧原子形成五元环或六元环。
• Structural studies by nuclear magnetic resonance—XVIII
  作者：G.J. Karabatsos、S.S. Lande

  DOI：10.1016/s0040-4020(01)92599-2

  日期：1968.1

  Conformations and configurations were assigned to several N-Me imines and N-alkyl acetaldimines from analyses of their 60-Mc NMR spectra. All aldimines exist exclusively in the syn configuration. Interpretation of the vicinal and long-range (across 4 and 5 and bonds) spin-spin coupling constants of N-Me aldimines led to the conclusion that I and II are the minimum energy conformations of these compounds

  通过对它们的60-Mc NMR光谱进行分析，将构象和构型分配给了几种N-Me亚胺和N-烷基乙二胺。所有醛亚胺仅以syn构型存在。N-Me Aldimines的邻位和远距离（跨4和5和键）自旋-自旋耦合常数的解释得出以下结论：I和II是这些化合物的最小能量构象。I⇌II的ΔH°值介于通常为负数的醛和为正数的肟及其O-甲基醚之间。N-烷基乙缩醛亚胺的长距离自旋-自旋偶合常数的解释（跨越4和5个键）得出以下结论：III比IV稳定得多。